SILO PHARMA, INC. Intangible Assets, Current
SILO PHARMA, INC. (SILO) had Intangible Assets, Current of $197.40 thousand as of 2025-05-31, per its 10-Q filed 2025-11-13.
Financial Statements › Notes › Goodwill and Other
us-gaap:IntangibleAssetsCurrent · last filed 2025-11-13
- 2025-05-31: Intangible Assets, Current $197.40K.
| Period end | Intangible Assets, Current |
|---|---|
| 2025-05-31 | $197.40K 10-Q · filed 2025-11-13 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Genprex, Inc. (GNPX) | United States | $0.003B | -0.02 |
| Alaunos Therapeutics, Inc. (TCRT) | United States | $0.003B | -1.44 |
| GeoVax Labs, Inc. (GOVX) | United States | $0.003B | -0.45 |
| Petros Pharmaceuticals, Inc. (PTPI) | United States | $0.003B | |
| Sunshine Biopharma Inc. (SBFM) | $0.003B | ||
| Matinas BioPharma Holdings, Inc. (MTNB) | United States | $0.003B | |
| ZyVersa Therapeutics, Inc. (ZVSA) | United States | $0.002B | |
| Aptevo Therapeutics Inc. (APVO) | United States | $0.003B | |
| BioXcel Therapeutics, Inc. (BTAI) | United States | $0.002B | |
| JUPITER NEUROSCIENCES, INC. (JUNS) | United States | $0.002B | -0.02 |